The Chief Financial Officer – CFO – does far more than manage finances. They enable scientific vision through strategic capital management.

In an industry where companies often operate without revenue for years, skilled CFOs are a vital component in a biotech’s success.

They build the models that connect scientific progress with financial milestones, and ensure there’s enough runway to reach the next inflection point.

Working closely with the CEO, a CFO will allocate resources across competing priorities, as well as helping translate scientific progress into financial language for investors – explaining how pre-revenue value is created through milestone achievements.

If recruitment is delayed or under-resourced, costs rise and confidence drops.

So a finance-savvy biotech ensures that patient recruitment isn’t just operational, it’s part of financial planning and risk mitigation.

Which is why the most effective CFOs understand that while patient recruitment may require significant investment, recruitment delays are ultimately far more costly.